Search:
   

Wednesday, May 20, 2015

Equity Trader Alert #2015 - 72
Reverse Split and CUSIP Change for Lexicon Pharmaceuticals, Inc. (LXRX)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Lexicon Pharmaceuticals, Inc. (LXRX) will effect a one for seven (1-7) reverse stock split of its outstanding common stock. The reverse split will be effective at the opening of business on Thursday, May 21, 2015. In conjunction with the reverse split, the CUSIP number will change to 528872302.

If you would like to register as a market maker in LXRX, contact Nasdaq Trading Services at +1 212 231 5100.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile